ARCHIVES

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

Seattle Cancer Care Alliance Marks its 10th Anniversary—January 2011

June 28, 2021

BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions

July 4, 2014

RFA: Long-Term Cancer Survivors

September 12, 1997

Garb Points Out Cancer Program Is Saving ore Lives a Year Than Polio Vaccine

April 6, 1979

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Clinical Trials Approved by NCI CTEP Last Month

August 26, 2011